HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sanshiro Okamoto Selected Research
Sanshiro Okamoto Research Topics
Disease
10
Neoplasms (Cancer)
01/2022 - 11/2003
6
Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 12/2004
5
Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 05/2009
5
Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2021 - 11/2013
5
Carcinoma (Carcinomatosis)
01/2021 - 09/2017
2
Anastomotic Leak
03/2021 - 01/2018
2
Endometrioid Carcinoma
03/2018 - 06/2007
2
Adenocarcinoma
09/2017 - 06/2007
2
Clear Cell Adenocarcinoma
02/2015 - 06/2007
2
Neoplasm Metastasis (Metastasis)
02/2015 - 01/2015
1
Endometrial Hyperplasia
01/2022
1
Uterine Neoplasms (Uterine Cancer)
01/2022
1
Internal Hernia
01/2021
1
Disease Progression
09/2020
1
Margins of Excision
01/2019
1
Sarcoma (Soft Tissue Sarcoma)
01/2019
1
Menstruation Disturbances
03/2018
1
Adenomyoma
03/2018
1
Lymphatic Metastasis
09/2017
1
Vaginal Diseases
02/2015
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2015
1
Cysts
05/2009
1
Peripheral Nervous System Diseases (PNS Diseases)
12/2004
1
Ovarian Epithelial Carcinoma
12/2004
1
Carcinosarcoma
11/2003
Drug/Important Bio-Agent (IBA)
4
Platinum
IBA
09/2017 - 12/2004
2
Progestins (Progestagens)
IBA
01/2022 - 03/2018
2
Hormones (Hormone)
IBA
01/2019 - 03/2018
2
Antigens
IBA
09/2017 - 05/2009
2
Paclitaxel (Taxol)
FDA Link
Generic
06/2007 - 12/2004
1
Bevacizumab (Avastin)
FDA Link
09/2020
1
Medroxyprogesterone Acetate (Depo-Provera)
FDA Link
Generic
03/2018
1
Diethylstilbestrol (Stilbestrol)
FDA Link
02/2015
1
sparfosic acid (PALA)
IBA
01/2015
1
Indicators and Reagents (Reagents)
IBA
11/2013
1
Cadherins (E-Cadherin)
IBA
05/2009
1
Vimentin
IBA
05/2009
1
Thrombomodulin
IBA
05/2009
1
tumor-associated antigen 72
IBA
05/2009
1
Calbindin 2
IBA
05/2009
1
Proteins (Proteins, Gene)
FDA Link
06/2007
1
Pharmaceutical Preparations
IBA
12/2004
1
Carboplatin (JM8)
FDA Link
Generic
12/2004
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
11/2003
1
Oncogene Proteins (Oncogene Protein)
IBA
11/2003
Therapy/Procedure
8
Drug Therapy (Chemotherapy)
01/2022 - 12/2004
5
Hysterectomy
05/2019 - 05/2009
4
Radiotherapy
01/2021 - 02/2015
4
Therapeutics
01/2019 - 09/2017
3
Salpingo-oophorectomy
12/2021 - 05/2009
3
Pelvic Exenteration
01/2021 - 01/2018
3
Lymph Node Excision (Lymph Node Dissection)
01/2021 - 01/2015
2
Cytoreduction Surgical Procedures
03/2021 - 09/2017
2
Brachytherapy
07/2020 - 04/2015
2
Aftercare (After-Treatment)
03/2018 - 02/2015
2
Chemoradiotherapy
09/2017 - 02/2015
2
Neoadjuvant Therapy
02/2015 - 07/2014
1
Adjuvant Chemotherapy
01/2022
1
Conservative Treatment
01/2022
1
Trachelectomy
09/2021
1
Length of Stay
03/2021
1
Operative Surgical Procedures
05/2019
1
Ileostomy
01/2018
1
Nephroureterectomy
09/2017
1
Combination Drug Therapy (Combination Chemotherapy)
12/2004